Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-08

Clinical Trial Update: Continuing Evaluation of the LungPoint ATV System [NA]

View source ↗

Summary

A clinical trial evaluating the LungPoint ATV System for lung cancer appears to have terminated, with the sponsor indicating the study status is TERMINATED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LungPoint ATV System

Snippet

Sponsor: Broncus Medical Inc | Conditions: Lung Cancer | NA | Status: TERMINATED